drugset / Trial / NCT03106532

Evaluation of PHP-201 Ophthalmic Solution in Patients With Normal Tension Glaucoma

NCT03106532 ↗

Phase 2 Completed 119 enrolled pH Pharma
RandomizedParallel-groupDouble-blindTreatment

Summary

Evaluation of the optimal dose for the efficacy in reduction of intraocular pressure and safety of PHP-201 ophthalmic solution in patients with normal tension glaucoma

Timeline

Start
2017-03-06
Primary completion
2018-05-02
Completion
2018-05-02

Drugs

EvaluationDrugModalityDoseRoute
Subject AMA0076 Unknown 0.25 % —
Subject AMA0076 Unknown 0.5 % —

Indications